---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-013257"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2024-02-09T23:59:59+00:00"
generated_at: "2026-06-06T04:57:21.000714+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical regains Nasdaq market value rule; still below $1 bid; hearing Mar 12

## Summary
- Regained compliance with Nasdaq Market Value Rule ($35M minimum) as of Feb 6, 2024.
- Remains non-compliant with Minimum Bid Price Rule ($1.00) for 30+ business days.
- Hearing before Nasdaq Hearings Panel scheduled March 12, 2024 to present cure plan.
- Common stock continues trading on Nasdaq Capital Market under 'ICU' pending Panel decision.

## SEC filing metadata
- accession: 0000950170-24-013257
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2024-02-09T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000095017024013257/0000950170-24-013257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000095017024013257/icu-20240206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-013257
- JSON: https://secwatch.observer/filing/0000950170-24-013257.json
- Plain text: https://secwatch.observer/filing/0000950170-24-013257.txt

## Key facts
- Listing & Compliance Notices
  SeaStar Medical Holding Corp received a nasdaq hearing update notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: hearing update
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: February 6, 2024, the Company received notification from the Staff that the Company had regained compliance with the Market Value Rule. However, the Staff indicated the Company remains non-compliant with the Minimum Bid Price Rule and therefore, as previously disclosed, the Company should present its views with respect to this deficiency at its scheduled hearing in front of the Nasdaq Hearings Panel (the “Panel”) on March 12, 2024 (the “ Hearing ”). At the hearing, the Company will present its plan to regain compliance with the Minimum Bid Price Rule. Subject to the final written decision by t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831868/000095017024013257/0000950170-24-013257-index.htm
- Listing & Compliance Notices
  SeaStar Medical Holding Corp received a nasdaq compliance regained notice regarding market value (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: market value
  - Rules: 5550(b)(2)
  source text: February 6, 2024, the Company received notification from the Staff that the Company had regained compliance with the Market Value Rule. However, the Staff indicated the Company remains non-compliant with the Minimum Bid Price Rule and therefore, as previously disclosed, the Company should present its views with respect to this deficiency at its scheduled hearing in front of the Nasdaq Hearings Panel (the “Panel”) on March 12, 2024 (the “ Hearing ”). At the hearing, the Company will present its plan to regain compliance with the Minimum Bid Price Rule. Subject to the final written decision by t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831868/000095017024013257/0000950170-24-013257-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.